Isis – SBS Fellowships 2010 Announced
Oxford University Innovation has awarded two three-month fellowships to MBAs graduating from the University’s Saïd Business School this summer.
We publish news of technology innovations, investment opportunities, together with updates from spin-out & start-up companies and licensees
Oxford University Innovation has awarded two three-month fellowships to MBAs graduating from the University’s Saïd Business School this summer.
In 2009 Oxford University Consulting provided an expert with the right mix of scientific credentials and management experience to join a team for an independent review of one of the UK’s most respected public institutions, the Royal Botanic Gardens, Kew.
Since it was launched in 2004, Oxford University’s Executive MBA programme has attracted entrepreneurial participants from around the world. Company owners and entrepreneurs comprise around ten per cent of the Oxford Executive MBA class, but the ninety per cent of employed participants also benefit from the programme’s focus on entrepreneurship and innovation.
University of Oxford climate change expert Dr Myles Allen has provided state-of-the-art climate science for Oxfordshire games company Red Redemption’s "Fate of the World" game – currently scheduled for release in the third quarter of 2010. Dr Allen’s consultancy to the company was arranged by Oxford University Consulting, a division of Oxford University Innovation, the University’s technology transfer company.
Oxford start-up Plink Search Ltd has become the first UK company to be purchased by Google Inc.
Lyons and Clermont-Ferrand (France): Biopharmaceutical company Imaxio announced today that it has entered a reciprocal license agreement with Oxford University Innovation, the technology transfer arm of Oxford University, to exploit know-how arising out of joint research at one of the world's premier research institutions, Oxford’s Jenner Institute, for the development of new vaccines. This agreement will allow Imaxio to use its proprietary aXent adjuvant technology with viral vectors such as Modified Vaccinia Ankara (MVA) and adenoviruses. The University of Oxford is internationally recognised for its expertise in the creation and development of virally vectored vaccines.
Oxford University Innovation, the University of Oxford’s technology transfer company, is working with researchers to commercialise a hydrogel material which promises better treatment for cleft palates - a birth defect that affects 1 in 700 babies in the UK.
Three-dimensional animated graphics can be merged into live video in real time to create a fusion of real and computer-generated visuals by software created at the University of Oxford’s Department of Engineering Science.
A simple and cheap way of making vaccines stable – even at tropical temperatures – has been developed by scientists at Oxford University and Nova Bio-Pharma Technologies.
Oxford University Innovation project managers will be offering free, confidential innovation workshops as part of the conference.